Asymmetric α-benzylation of cyclic ketones enabled by concurrent chemical aldol condensation and biocatalytic reduction

Abstract Chemoenzymatic cascade catalysis has emerged as a revolutionary tool for streamlining traditional retrosynthetic disconnections, creating new possibilities for the asymmetric synthesis of valuable chiral compounds. Here we construct a one-pot concurrent chemoenzymatic cascade by integrating...

Full description

Bibliographic Details
Main Authors: Yunting Liu, Teng Ma, Zhongxu Guo, Liya Zhou, Guanhua Liu, Ying He, Li Ma, Jing Gao, Jing Bai, Frank Hollmann, Yanjun Jiang
Format: Article
Language:English
Published: Nature Portfolio 2024-01-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-44452-z
_version_ 1797363054183186432
author Yunting Liu
Teng Ma
Zhongxu Guo
Liya Zhou
Guanhua Liu
Ying He
Li Ma
Jing Gao
Jing Bai
Frank Hollmann
Yanjun Jiang
author_facet Yunting Liu
Teng Ma
Zhongxu Guo
Liya Zhou
Guanhua Liu
Ying He
Li Ma
Jing Gao
Jing Bai
Frank Hollmann
Yanjun Jiang
author_sort Yunting Liu
collection DOAJ
description Abstract Chemoenzymatic cascade catalysis has emerged as a revolutionary tool for streamlining traditional retrosynthetic disconnections, creating new possibilities for the asymmetric synthesis of valuable chiral compounds. Here we construct a one-pot concurrent chemoenzymatic cascade by integrating organobismuth-catalyzed aldol condensation with ene-reductase (ER)-catalyzed enantioselective reduction, enabling the formal asymmetric α-benzylation of cyclic ketones. To achieve this, we develop a pair of enantiocomplementary ERs capable of reducing α-arylidene cyclic ketones, lactams, and lactones. Our engineered mutants exhibit significantly higher activity, up to 37-fold, and broader substrate specificity compared to the parent enzyme. The key to success is due to the well-tuned hydride attack distance/angle and, more importantly, to the synergistic proton-delivery triade of Tyr28-Tyr69-Tyr169. Molecular docking and density functional theory (DFT) studies provide important insights into the bioreduction mechanisms. Furthermore, we demonstrate the synthetic utility of the best mutants in the asymmetric synthesis of several key chiral synthons.
first_indexed 2024-03-08T16:16:20Z
format Article
id doaj.art-6c95bcee20e245c99385a40a80515b93
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-03-08T16:16:20Z
publishDate 2024-01-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-6c95bcee20e245c99385a40a80515b932024-01-07T12:34:59ZengNature PortfolioNature Communications2041-17232024-01-011511910.1038/s41467-023-44452-zAsymmetric α-benzylation of cyclic ketones enabled by concurrent chemical aldol condensation and biocatalytic reductionYunting Liu0Teng Ma1Zhongxu Guo2Liya Zhou3Guanhua Liu4Ying He5Li Ma6Jing Gao7Jing Bai8Frank Hollmann9Yanjun Jiang10School of Chemical Engineering and Technology, Hebei University of TechnologySchool of Chemical Engineering and Technology, Hebei University of TechnologySchool of Chemical Engineering and Technology, Hebei University of TechnologySchool of Chemical Engineering and Technology, Hebei University of TechnologySchool of Chemical Engineering and Technology, Hebei University of TechnologySchool of Chemical Engineering and Technology, Hebei University of TechnologySchool of Chemical Engineering and Technology, Hebei University of TechnologySchool of Chemical Engineering and Technology, Hebei University of TechnologyCollege of Food Science and Biology, Hebei University of Science & TechnologyDepartment of Biotechnology, Delft University of TechnologySchool of Chemical Engineering and Technology, Hebei University of TechnologyAbstract Chemoenzymatic cascade catalysis has emerged as a revolutionary tool for streamlining traditional retrosynthetic disconnections, creating new possibilities for the asymmetric synthesis of valuable chiral compounds. Here we construct a one-pot concurrent chemoenzymatic cascade by integrating organobismuth-catalyzed aldol condensation with ene-reductase (ER)-catalyzed enantioselective reduction, enabling the formal asymmetric α-benzylation of cyclic ketones. To achieve this, we develop a pair of enantiocomplementary ERs capable of reducing α-arylidene cyclic ketones, lactams, and lactones. Our engineered mutants exhibit significantly higher activity, up to 37-fold, and broader substrate specificity compared to the parent enzyme. The key to success is due to the well-tuned hydride attack distance/angle and, more importantly, to the synergistic proton-delivery triade of Tyr28-Tyr69-Tyr169. Molecular docking and density functional theory (DFT) studies provide important insights into the bioreduction mechanisms. Furthermore, we demonstrate the synthetic utility of the best mutants in the asymmetric synthesis of several key chiral synthons.https://doi.org/10.1038/s41467-023-44452-z
spellingShingle Yunting Liu
Teng Ma
Zhongxu Guo
Liya Zhou
Guanhua Liu
Ying He
Li Ma
Jing Gao
Jing Bai
Frank Hollmann
Yanjun Jiang
Asymmetric α-benzylation of cyclic ketones enabled by concurrent chemical aldol condensation and biocatalytic reduction
Nature Communications
title Asymmetric α-benzylation of cyclic ketones enabled by concurrent chemical aldol condensation and biocatalytic reduction
title_full Asymmetric α-benzylation of cyclic ketones enabled by concurrent chemical aldol condensation and biocatalytic reduction
title_fullStr Asymmetric α-benzylation of cyclic ketones enabled by concurrent chemical aldol condensation and biocatalytic reduction
title_full_unstemmed Asymmetric α-benzylation of cyclic ketones enabled by concurrent chemical aldol condensation and biocatalytic reduction
title_short Asymmetric α-benzylation of cyclic ketones enabled by concurrent chemical aldol condensation and biocatalytic reduction
title_sort asymmetric α benzylation of cyclic ketones enabled by concurrent chemical aldol condensation and biocatalytic reduction
url https://doi.org/10.1038/s41467-023-44452-z
work_keys_str_mv AT yuntingliu asymmetricabenzylationofcyclicketonesenabledbyconcurrentchemicalaldolcondensationandbiocatalyticreduction
AT tengma asymmetricabenzylationofcyclicketonesenabledbyconcurrentchemicalaldolcondensationandbiocatalyticreduction
AT zhongxuguo asymmetricabenzylationofcyclicketonesenabledbyconcurrentchemicalaldolcondensationandbiocatalyticreduction
AT liyazhou asymmetricabenzylationofcyclicketonesenabledbyconcurrentchemicalaldolcondensationandbiocatalyticreduction
AT guanhualiu asymmetricabenzylationofcyclicketonesenabledbyconcurrentchemicalaldolcondensationandbiocatalyticreduction
AT yinghe asymmetricabenzylationofcyclicketonesenabledbyconcurrentchemicalaldolcondensationandbiocatalyticreduction
AT lima asymmetricabenzylationofcyclicketonesenabledbyconcurrentchemicalaldolcondensationandbiocatalyticreduction
AT jinggao asymmetricabenzylationofcyclicketonesenabledbyconcurrentchemicalaldolcondensationandbiocatalyticreduction
AT jingbai asymmetricabenzylationofcyclicketonesenabledbyconcurrentchemicalaldolcondensationandbiocatalyticreduction
AT frankhollmann asymmetricabenzylationofcyclicketonesenabledbyconcurrentchemicalaldolcondensationandbiocatalyticreduction
AT yanjunjiang asymmetricabenzylationofcyclicketonesenabledbyconcurrentchemicalaldolcondensationandbiocatalyticreduction